Cash Flow Austar Lifesciences Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
22.00
-45.00
127.00
371.00
34.00
2.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
28.00
-212.00
-288.00
-254.00
20.00
-17.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
92.00
-153.00
-128.00
-69.00
107.00
29.00
Cash Flow from Investing Activities
3.00
-65.00
-178.00
70.00
-75.00
-26.00
Cash Flow from Financing Activities
-91.00
177.00
150.00
76.00
-2.00
-18.00
Net Cash Inflow / Outflow
5.00
-41.00
-154.00
78.00
29.00
-15.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
1.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Austar Lifesciences Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
22.6320884884373
1308.99753996554
-1,286.00
-98.27%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
28.7568689747448
-646.135609373614
674.00
104.45%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
92.5363365100675
971.654302056396
-879.00
-90.48%
Cash Flow from Investing Activities
3.77309897191539
-440.877941077574
443.00
100.86%
Cash Flow from Financing Activities
-91.5366821272784
-340.106924483685
249.00
73.09%
Net Cash Inflow / Outflow
5.99575784904946
188.714580907107
-183.00
-96.82%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.22300449434499
-1.95485558803547
2.00
162.56%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 160.23% vs -19.65% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
92.54
-153.65
160.23%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
